| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
22,521 |
11,465 |
$25.08M |
| J1602 |
Injection, golimumab, 1 mg, for intravenous use |
5,053 |
2,937 |
$7.06M |
| J0490 |
Injection, belimumab, 10 mg |
4,949 |
1,855 |
$5.41M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
20,948 |
18,222 |
$4.09M |
| Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg |
2,680 |
1,558 |
$3.89M |
| J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
526 |
461 |
$1.33M |
| 96415 |
|
15,105 |
13,116 |
$1.31M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,015 |
14,195 |
$672K |
| 20610 |
|
8,901 |
7,473 |
$547K |
| J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
373 |
265 |
$527K |
| 77080 |
|
5,259 |
4,895 |
$467K |
| J7323 |
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose |
604 |
336 |
$347K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,766 |
4,543 |
$292K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
7,641 |
6,278 |
$210K |
| J0897 |
Injection, denosumab, 1 mg |
431 |
367 |
$174K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
7,803 |
7,538 |
$167K |
| 96401 |
|
2,317 |
1,899 |
$142K |
| 90750 |
|
795 |
755 |
$119K |
| 73100 |
|
3,591 |
2,514 |
$102K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,612 |
1,936 |
$91K |
| 73120 |
|
3,613 |
2,523 |
$91K |
| 73560 |
|
2,948 |
2,025 |
$82K |
| J3489 |
Injection, zoledronic acid, 1 mg |
1,510 |
1,266 |
$79K |
| 72110 |
|
1,974 |
1,877 |
$77K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
429 |
429 |
$75K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,461 |
4,036 |
$68K |
| 20550 |
|
1,903 |
1,791 |
$64K |
| 20605 |
|
1,655 |
1,543 |
$61K |
| 73030 |
|
1,556 |
1,120 |
$51K |
| 20611 |
|
607 |
353 |
$50K |
| J2357 |
Injection, omalizumab, 5 mg |
41 |
26 |
$45K |
| 20600 |
|
995 |
902 |
$43K |
| 71046 |
Radiologic examination, chest; 2 views |
1,371 |
1,322 |
$41K |
| 73600 |
|
1,353 |
899 |
$40K |
| 73620 |
|
1,347 |
900 |
$39K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
415 |
348 |
$37K |
| 90688 |
|
2,923 |
2,721 |
$34K |
| 90732 |
|
409 |
375 |
$32K |
| 90670 |
|
243 |
238 |
$32K |
| 96367 |
|
1,056 |
934 |
$29K |
| 73521 |
|
826 |
771 |
$26K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
4,741 |
3,659 |
$24K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
4,483 |
3,414 |
$23K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
24 |
13 |
$19K |
| 64493 |
|
63 |
63 |
$14K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
581 |
497 |
$13K |
| 73070 |
|
289 |
258 |
$12K |
| 99215 |
Prolong outpt/office vis |
170 |
167 |
$12K |
| 72202 |
|
402 |
370 |
$12K |
| J7321 |
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
304 |
142 |
$11K |
| 72040 |
|
404 |
379 |
$11K |
| 90715 |
|
228 |
223 |
$10K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
216 |
205 |
$10K |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
943 |
826 |
$9K |
| 73565 |
|
318 |
318 |
$8K |
| 99243 |
|
37 |
37 |
$5K |
| 64494 |
|
50 |
50 |
$4K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,602 |
3,512 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
58 |
44 |
$4K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,323 |
3,326 |
$4K |
| 90671 |
|
14 |
14 |
$3K |
| S0028 |
Injection, famotidine, 20 mg |
3,042 |
2,589 |
$3K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
569 |
468 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
594 |
403 |
$2K |
| 77002 |
|
41 |
41 |
$780.52 |
| 72200 |
|
13 |
13 |
$466.67 |
| 72070 |
|
14 |
14 |
$390.39 |
| 90661 |
|
26 |
25 |
$292.98 |
| 95117 |
|
121 |
49 |
$196.85 |
| G0008 |
Administration of influenza virus vaccine |
622 |
497 |
$188.96 |
| 99406 |
|
17 |
17 |
$186.68 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
106 |
105 |
$50.63 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
1,038 |
927 |
$0.00 |
| 90653 |
|
13 |
13 |
$0.00 |
| 90662 |
|
51 |
39 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
122 |
113 |
$0.00 |
| G0009 |
Administration of pneumococcal vaccine |
26 |
25 |
$0.00 |